The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

被引:205
作者
Mocellin, S
Marincola, F
Rossi, CR
Nitti, D
Lise, M
机构
[1] Univ Padua, Clin Chirurg 2, Dept Oncol & Surg Sci, I-35128 Padua, Italy
[2] NIH, Dept Transfus Med, Immunogenet Sect, Bethesda, MD USA
关键词
IL-10; adaptive immunity; cytotoxic T lymphocyte;
D O I
10.1016/j.cytogfr.2003.11.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-10 (IL-10) is a pleiotropic cytokine that modulates the function of several adaptive immunity-related cells. Although generally considered an immunosuppressive molecule, IL-10 possesses immunostimulatory properties in several in vitro and in vivo models. These very different outcomes are believed to depend upon experimental conditions, the dominant immune effector mediating a given immune response, the timing of IL-10 production/administration, and IL-10 dose and/or location of expression. In the present work, we review the current knowledge regarding IL-10 activity on adaptive immunity related cells, emphasize new insights on IL-10 molecular/cellular targets, and summarize the available data on the relationship between IL-10 and some pathological conditions (e.g. infectious diseases, autoimmunity, allergy, cancer and transplantation) involving adaptive immunity. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 220 条
[81]  
Groux H, 1999, J IMMUNOL, V162, P1723
[82]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[83]  
Groux H, 1998, J IMMUNOL, V160, P3188
[84]   Interleukin-10 induces a long-term antigen-specific anergic state in human CD4(+) T cells [J].
Groux, H ;
Bigler, M ;
deVries, JE ;
Roncarolo, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :19-29
[85]   Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis [J].
Grunig, G ;
Corry, DB ;
Leach, MW ;
Seymour, BWP ;
Kurup, VP ;
Rennick, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (06) :1089-1099
[86]   Altered immune responses in interleukin 10 transgenic mice [J].
Hagenbaugh, A ;
Sharma, S ;
Dubinett, SM ;
Wei, SHY ;
Aranda, R ;
Cheroutre, H ;
Fowell, DJ ;
Binder, S ;
Tsao, B ;
Locksley, RM ;
Moore, KW ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) :2101-2110
[87]   Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production [J].
Hall, G ;
Houghton, CG ;
Rahbek, JU ;
Lamb, JR ;
Jarman, ER .
VACCINE, 2003, 21 (5-6) :549-561
[88]   Regulation of cytokine signaling and inflammation [J].
Hanada, T ;
Yoshimura, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :413-421
[89]   Histamine in cancer immunotherapy: A preclinical background [J].
Hellstrand, K .
SEMINARS IN ONCOLOGY, 2002, 29 (03) :35-40
[90]   High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation [J].
Hempel, L ;
Korholz, D ;
Nussbaum, P ;
Bonig, H ;
Burdach, S ;
Zintl, F .
BONE MARROW TRANSPLANTATION, 1997, 20 (05) :365-368